ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Brookfield Wealth Solutions Ltd

Brookfield Wealth Solutions Ltd (9JG)

58.50
1.00
(1.74%)
Closed January 25 4:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
58.50
Bid
57.50
Ask
58.50
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
57.50
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
145,466,310
Dividend Yield
-
PE Ratio
8.60
Earnings Per Share (EPS)
5.48
Revenue
7.02B
Net Profit
797M

About Brookfield Wealth Solutions Ltd

Sector
Insurance Carriers, Nec
Industry
Insurance Carriers, Nec
Headquarters
Hamilton, Bmu
Founded
-
Brookfield Wealth Solutions Ltd is listed in the Insurance Carriers sector of the Tradegate (DE) with ticker 9JG. The last closing price for Brookfield Wealth Soluti... was 57.50 €. Over the last year, Brookfield Wealth Soluti... shares have traded in a share price range of 0.00 € to 0.00 €.

Brookfield Wealth Soluti... currently has 145,466,310 shares outstanding. The market capitalization of Brookfield Wealth Soluti... is 8.36 € billion. Brookfield Wealth Soluti... has a price to earnings ratio (PE ratio) of 8.60.

9JG Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

9JG - Frequently Asked Questions (FAQ)

What is the current Brookfield Wealth Soluti... share price?
The current share price of Brookfield Wealth Soluti... is 58.50 €
How many Brookfield Wealth Soluti... shares are in issue?
Brookfield Wealth Soluti... has 145,466,310 shares in issue
What is the market cap of Brookfield Wealth Soluti...?
The market capitalisation of Brookfield Wealth Soluti... is EUR 8.36B
What is the 1 year trading range for Brookfield Wealth Soluti... share price?
Brookfield Wealth Soluti... has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Brookfield Wealth Soluti...?
The price to earnings ratio of Brookfield Wealth Soluti... is 8.6
What is the cash to sales ratio of Brookfield Wealth Soluti...?
The cash to sales ratio of Brookfield Wealth Soluti... is 0.98
What is the reporting currency for Brookfield Wealth Soluti...?
Brookfield Wealth Soluti... reports financial results in USD
What is the latest annual turnover for Brookfield Wealth Soluti...?
The latest annual turnover of Brookfield Wealth Soluti... is USD 7.02B
What is the latest annual profit for Brookfield Wealth Soluti...?
The latest annual profit of Brookfield Wealth Soluti... is USD 797M
What is the registered address of Brookfield Wealth Soluti...?
The registered address for Brookfield Wealth Soluti... is 73 FRONT STREET, 5TH FLOOR, HAMILTON, HM 12
What is the Brookfield Wealth Soluti... website address?
The website address for Brookfield Wealth Soluti... is www.bam.brookfield.com
Which industry sector does Brookfield Wealth Soluti... operate in?
Brookfield Wealth Soluti... operates in the INSURANCE CARRIERS, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M

Discussion

View Full Feed
oldmystic oldmystic 27 seconds ago
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 49 seconds ago
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 50 seconds ago
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 56 seconds ago
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 1 minute ago
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 1 minute ago
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 2 minutes ago
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 2 minutes ago
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 3 minutes ago
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 3 minutes ago
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 3 minutes ago
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 4 minutes ago
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 7 minutes ago
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 7 minutes ago
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 9 minutes ago
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 10 minutes ago
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 10 minutes ago
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 11 minutes ago
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL

Your Recent History

Delayed Upgrade Clock